Viridian Therapeutics board compensation committee approves inducement grants

Sep. 02, 2022 8:27 AM ETViridian Therapeutics, Inc. (VRDN)By: Mary Christine Joy, SA News Editor
  • Biotechnology company Viridian Therapeutics (NASDAQ:VRDN) said a majority in the board's compensation committee have approved the grant of stock options to purchase an aggregate of 103K shares to three new employees on Sep. 1.
  • The inducement grants have an exercise price per share equal to the company's closing price on the grant date.
  • The inducement grants will vest over a four-year period.
  • Source: Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.